Loop monitor to watch heart rhythms when starting a BTK inhibitor
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study checks how often abnormal heart rhythms happen when you start a BTK inhibitor (used for certain blood cancers). It uses a small implanted heart monitor to record your rhythm continuously before and after starting the medication, so doctors can detect and manage problems early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You agree to sign a consent form
- You agree to remote monitoring (sharing your data with the study team)
- You are starting a BTK inhibitor for an approved condition such as CLL or Waldenström’s
- You are willing to have a small implantable heart monitor placed for at least 24 hours of continuous recording before starting the BTK inhibitor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches for high blood pressure and irregular heartbeats in people with CLL who are starting a type of targeted therapy called a BTK inhibitor (acalabrutinib or zanubrutinib). Researchers will use a smartwatch and blood pressure cuff to monitor your heart health at home.
This study uses a small device placed under the skin to continuously monitor your heart rhythm while you take a BTK inhibitor (a type of targeted therapy for blood cancer). The goal is to catch irregular heartbeats early, which can be a side effect of these medicines.
This study looks at whether certain blood cancer treatments increase the risk of an irregular heartbeat called atrial fibrillation. It may help doctors understand which patients need closer heart monitoring.
This trial is testing a special monitor (BIOMONITOR) that tracks your heart function and sends data wirelessly to your doctor. It aims to help manage heart failure by catching early signs of trouble so you can get treatment sooner.
This study uses a small implantable heart monitor to track heart rhythm in people after an acute ischemic stroke or TIA. It aims to learn how often hidden heart rhythm problems show up, which could help doctors choose better stroke prevention treatments.
This study looks at how well blood pressure is managed and whether heart problems can be prevented in people with certain blood cancers who are taking a type of targeted therapy called a BTKi. It aims to help you stay healthier during treatment.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.